Literature DB >> 6359903

The seroepidemiology of malaria in Middle America. V. Antibody responses in an indicator population from an endemic area with attack phase antimalaria activities.

M Warren, W E Collins, G M Jeffery, J C Skinner.   

Abstract

Serologic assessment was carried out in a sample of the population living in an area endemic for malaria in which control measures were being applied. The study area was in El Salvador, Central America, and antimalarial activities consisted of the residual application of the pesticide, propoxur, and drug distribution through a combination of active and passive case detection. Indirect fluorescent antibody (IFA) responses to Plasmodium vivax and P. falciparum antigens were determined on four occasions, at approximately 6-month intervals. The study population consisted of one resident from each of 268 widely distributed houses. Each person was treated with a curative course of chloroquine and primaquine at the beginning of the investigation. An increase in the proportion of positive IFA responses (greater than or equal to 1:20) and an increasing number of serologic conversions (i.e., from negative to positive or a 2-fold increase in titer) during the course of the 18-month study confirmed continued transmission of malaria. The presence of parasites in some individuals without associated serologic changes is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6359903

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  2 in total

1.  The seroprevalence of cysticercosis, malaria, and Trypanosoma cruzi among North Carolina migrant farmworkers.

Authors:  S Ciesielski; J R Seed; J Estrada; E Wrenn
Journal:  Public Health Rep       Date:  1993 Nov-Dec       Impact factor: 2.792

2.  Genome-Scale Protein Microarray Comparison of Human Antibody Responses in Plasmodium vivax Relapse and Reinfection.

Authors:  Raul Chuquiyauri; Douglas M Molina; Eli L Moss; Ruobing Wang; Malcolm J Gardner; Kimberly C Brouwer; Sonia Torres; Robert H Gilman; Alejandro Llanos-Cuentas; Daniel E Neafsey; Philip Felgner; Xiaowu Liang; Joseph M Vinetz
Journal:  Am J Trop Med Hyg       Date:  2015-07-06       Impact factor: 2.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.